Biomarker-guided drug therapy: personalized medicine for treating Alzheimer's disease

被引：1
|
作者：
Charvi Syal [1 ]
Jing Wang [1 ,2 ,4 ]
机构：
[1] Regenerative Medicine Program, Ottawa Hospital Research Institute
[2] Department of Cellular and Molecular Medicine, Faculty of Medicine
来源：
Neural Regeneration Research | 2021年 / 16卷 / 10期
基金：
加拿大自然科学与工程研究理事会;
关键词：
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
Alzheimer’s disease(AD) is a progressive neurodegenerative disorder associated with significant memory decline and cognitive impairment. AD is characterized by two classical neuropathological hallmarks,
引用
收藏
页码：2010 / 2011
页数：2
相关论文
共 50 条
  • [21] Biomarker-guided therapy for colorectal cancer: strength in complexity
    Anita Sveen
    Scott Kopetz
    Ragnhild A. Lothe
    Nature Reviews Clinical Oncology, 2020, 17 : 11 - 32
  • [22] Promising use of metformin in treating neurological disorders: biomarker-guided therapies
    Loan, Allison
    Syal, Charvi
    Lui, Margarita
    He, Ling
    Wang, Jing
    NEURAL REGENERATION RESEARCH, 2024, 19 (05) : 1045 - 1055
  • [23] Biomarker-guided antibiotic therapy-strengths and limitations
    Nora, David
    Salluh, Jorge
    Martin-Loeches, Ignacio
    Povoa, Pedro
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (10)
  • [24] Biomarker-guided stratification of autoimmune patients for biologic therapy
    Ivison, Sabine
    Des Rosiers, Christine
    Lesage, Sylvie
    Rioux, John D.
    Levings, Megan K.
    CURRENT OPINION IN IMMUNOLOGY, 2017, 49 : 56 - 63
  • [25] Promising use of metformin in treating neurological disorders:biomarker-guided therapies
    Allison Loan
    Charvi Syal
    Margarita Lui
    Ling He
    Jing Wang
    Neural Regeneration Research, 2024, 19 (05) : 1045 - 1055
  • [26] Potential biomarker for amyloid clearance in Alzheimer's disease may enable personalized therapy
    不详
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (05) : 625 - 625
  • [27] Potential biomarker for amyloid clearance in Alzheimer's disease may enable personalized therapy
    不详
    PERSONALIZED MEDICINE, 2011, 8 (03) : 299 - 299
  • [28] Site-agnostic biomarker-guided oncology drug development
    Jorgensen, Jan Trost
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (06) : 583 - 592
  • [29] Biomarker-guided personalised emergency medicine for all - hope for another hype?
    Schuetz, Philipp
    Aujesky, Drahomir
    Mueller, Christian
    Mueller, Beat
    SWISS MEDICAL WEEKLY, 2015, 145
  • [30] Biological and analytical variation of clinical biomarker testing: Implications for biomarker-guided therapy
    Wu A.H.B.
    Current Heart Failure Reports, 2013, 10 (4) : 434 - 440
12345